Interrupting endocrine therapy to attempt pregnancy after breast cancer
- Author(s):
- Partridge, A.H.; Niman, S.M.; Ruggeri, M.; Peccatori, F.A.; Azim, H.A.; Colleoni, M.; Saura, C.; Shimizu, C.; Sætersdal, A.B.; Kroep, J.R. (0000-0003-2671-1903); Mailliez, A.; Warner, E.; Borges, V.F.; Amant, F.; Gombos, A.; Kataoka, A.; Rousset-Jablonski, C.; Borstnar, S.; Takei, J.; Lee, J.E.; Walshe, J.M.; Ruíz-Borrego, M.; Moore, H.C.F.; Saunders, C.; Bjelic-Radisic, V.; Susnjar, S.; Cardoso, F.; Smith, K.L.; Ferreiro, T.; Ribi, K.; Ruddy, K.; Kammler, R.; El-Abed, S.; Viale, G.; Piccart, M.; Korde, L.A.; Goldhirsch, A.; Gelber, R.D.; Pagani, O.; Int Breast Canc Study Grp POSITIVE
- Published
- 2023
- Publication type
- Article / Letter to editor
- Date issued
- 2023-05-04
- Language
- English
- Is part of
- New England Journal of Medicine (2023), Vol. 388, no. 18, p. 1646-1656
- hdl
- 1887/3768519
- doi
- 10.1056/NEJMoa2212856
- URL
- https://www.nejm.org/doi/10.1056/NEJMoa2212856
